GF SECURITIES(SZ:000776) Mei Ri Jing Ji Xin Wen·2025-07-23 05:57Group 1 - The core industries in the Sci-Tech Innovation Board are characterized by hard technology, with the electronic core industry (44.07%), biopharmaceutical industry (15.92%), and intelligent manufacturing equipment industry (9.15%) being the top three by market capitalization [1] - The demand for high-performance computing is resonating with the penetration of AI from the cloud to the edge, leading to an accelerated price increase in DDR4 and triggering a server upgrade cycle [1] - The innovative drug industry is expected to achieve breakthroughs through License-out overseas, with a projected transaction scale of $51.9 billion in 2024, indicating a continuous growth trend [1] Group 2 - Revenue growth rates for the electronic core industry, artificial intelligence industry, and biopharmaceutical industry in 2024 are projected to be 17.39%, 28.44%, and 32.36% respectively, with significant profit expectations for the biopharmaceutical industry [1] - The R&D intensity of the Sci-Tech Innovation Board remains stable at around 11%, with total R&D investment expected to reach 154.68 billion yuan in 2024, fostering a virtuous cycle of R&D-driven growth [1] Group 3 - The Sci-Tech Innovation Board 100 ETF (588120) tracks the Sci-Tech 100 Index (000698), which can have a daily price fluctuation of up to 20%. This index is compiled by China Securities Index Co., Ltd. and includes 100 securities with moderate market capitalization and good liquidity, reflecting the overall performance of outstanding growth enterprises in high-tech and strategic emerging industries [1] - The Sci-Tech Comprehensive Index ETF (589630) tracks the Sci-Tech Comprehensive Index (000680), also allowing for a daily price fluctuation of up to 20%. This index, published by the Shanghai Stock Exchange, selects all eligible listed companies on the Sci-Tech Innovation Board to reflect the overall market performance [2]